Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional imaging with positron emission tomography in multiple system atrophy.

S Gilman1

  • 1Department of Neurology, University of Michigan, Ann Arbor, MI 48109-0489, USA. sgilman@umich.edu

Journal of Neural Transmission (Vienna, Austria : 1996)
|August 6, 2005
PubMed
Summary

Positron emission tomography (PET) imaging shows promise in diagnosing multiple system atrophy (MSA) by revealing distinct brain patterns. Further research is needed to confirm its accuracy in early-stage patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease.

Neurology·2011
Same author

TDP-43 pathology occurs infrequently in multiple system atrophy.

Neuropathology and applied neurobiology·2010
Same author

Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.

Neurology·2010
Same author

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

Neurology·2009
Same author

Immigration to the USA and risk for mood and anxiety disorders: variation by origin and age at immigration.

Psychological medicine·2008
Same author

Second consensus statement on the diagnosis of multiple system atrophy.

Neurology·2008

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Neurology

Background:

  • Current multiple system atrophy (MSA) diagnosis lacks mandatory neuroimaging.
  • Positron emission tomography (PET) has shown potential in differentiating MSA from other neurological disorders.
  • Existing PET studies primarily focus on advanced disease stages.

Purpose of the Study:

  • To evaluate the diagnostic utility of PET imaging in early-stage multiple system atrophy (MSA).
  • To assess the sensitivity and specificity of PET techniques for accurate MSA diagnosis.
  • To explore the role of PET in understanding peripheral and central nervous system involvement in MSA.

Main Methods:

  • Review of existing literature on PET imaging in MSA diagnosis.
  • Analysis of PET-demonstrated patterns of cerebral glucose utilization and nigrostriatal abnormalities.

Related Experiment Videos

  • Examination of recent PET studies on myocardial sympathetic denervation and neurochemical deficits.

    • Main Results:

    • PET imaging reveals distinct patterns of cerebral glucose metabolism and dopaminergic deficits in MSA compared to other conditions.
    • Evidence suggests MSA affects both central and peripheral nervous systems, including myocardial sympathetic neurons.
    • PET investigations offer insights into neurochemical underpinnings of sleep disturbances in MSA.

    Conclusions:

    • PET imaging holds diagnostic potential for multiple system atrophy (MSA), aiding differentiation from similar disorders.
    • Further studies are required to validate PET's sensitivity and specificity in early-stage MSA with clinical and autopsy correlation.
    • PET imaging contributes to understanding the broader neurochemical and systemic impact of MSA.